Shawver Laura

Track

Insider profile

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -57% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Shawver Laura's trades of ARS Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-08 2025-04-07
PlS Planned sale
69,178 +14.9%
167.06
US$2,297,710 		69,178 +14.9% 167.06 US$2,297,710
2025-04-07 2025-04-07
PrS Proposed sale
96,324
198.80
US$2,153,828 		96,324 198.80 US$2,153,828
2025-03-07 2025-03-06
PlS Planned sale
18,592 -31.9%
53.12
US$4,274,093 		18,592 -31.9% 53.12 US$4,274,093
2025-03-07 2025-03-05
PlS Planned sale
400 -0.2%
11.00
US$4,400 		400 -0.2% 11.00 US$4,400
2025-03-05 2025-03-05
PrS Proposed sale
50,000
11.00
US$550,000 		50,000 11.00 US$550,000
2025-02-04 2025-02-03
PlS Planned sale
50,000 -19.2%
12.31
US$615,565 		50,000 -19.2% 12.31 US$615,565
2025-02-03 2025-02-03
PrS Proposed sale
50,000
12.31
US$615,565 		50,000 12.31 US$615,565
2025-01-07 2025-01-06
PlS Planned sale
50,000 -19.2%
11.10
US$555,065 		50,000 -19.2% 11.10 US$555,065
2025-01-06 2025-01-06
PrS Proposed sale
50,000
11.10
US$555,065 		50,000 11.10 US$555,065
2024-12-04 2024-12-04
PlS Planned sale
14,772 -6.6%
13.75
US$203,109 		14,772 -6.6% 13.75 US$203,109
2024-12-04 2024-12-03
PlS Planned sale
87,984 -29.5%
13.26
US$1,166,897 		87,984 -29.5% 13.26 US$1,166,897
2024-12-09 2024-12-02
PrS Proposed sale
200,000
13.57
US$2,713,000 		200,000 13.57 US$2,713,000
2024-12-04 2024-12-02
PlS Planned sale
901 -0.4%
14.34
US$12,922 		901 -0.4% 14.34 US$12,922
2024-12-04 2024-12-02
PlS Planned sale
96,343 -31.3%
13.55
US$1,305,823 		96,343 -31.3% 13.55 US$1,305,823
2024-12-02 2024-12-02
PrS Proposed sale
200,000
13.57
US$2,713,000 		200,000 13.57 US$2,713,000
2023-09-05 2023-09-01
PlS Planned sale
100,000 -32.2%
7.71
US$770,520 		100,000 -32.2% 7.71 US$770,520
2023-09-01 2023-09-01
PrS Proposed sale
100,000
7.71
US$770,524 		100,000 7.71 US$770,524
2023-08-07 2023-08-04
PlS Planned sale
18,897 -8.2%
7.06
US$133,471 		18,897 -8.2% 7.06 US$133,471
2023-08-07 2023-08-03
PlS Planned sale
26,107 -11.0%
7.01
US$183,018 		26,107 -11.0% 7.01 US$183,018
2023-08-03 2023-08-02
PlS Planned sale
36,281 -14.7%
7.09
US$257,265 		36,281 -14.7% 7.09 US$257,265
2023-08-03 2023-08-01
PlS Planned sale
18,715 -8.2%
7.19
US$134,576 		18,715 -8.2% 7.19 US$134,576
2023-08-01 2023-08-01
PrS Proposed sale
100,000
7.20
US$720,000 		100,000 7.20 US$720,000
2023-07-07 2023-07-07
PlS Planned sale
8,858 -4.0%
6.36
US$56,372 		8,858 -4.0% 6.36 US$56,372
2023-07-06 2023-07-06
PlS Planned sale
33,510 -13.7%
6.34
US$212,554 		33,510 -13.7% 6.34 US$212,554
2023-07-06 2023-07-05
PlS Planned sale
31,112 -12.9%
6.41
US$199,552 		31,112 -12.9% 6.41 US$199,552
2023-07-06 2023-07-03
PlS Planned sale
26,520 -11.2%
6.73
US$178,347 		26,520 -11.2% 6.73 US$178,347
2023-07-03 2023-07-03
PrS Proposed sale
100,000
6.68
US$668,450 		100,000 6.68 US$668,450
2023-06-02 2023-06-02
PlS Planned sale
26,941 -11.4%
6.95
US$187,240 		26,941 -11.4% 6.95 US$187,240
2023-06-02 2023-06-01
PlS Planned sale
73,059 -25.8%
6.80
US$496,801 		73,059 -25.8% 6.80 US$496,801
2023-06-01 2023-06-01
PrS Proposed sale
100,000
6.80
US$680,000 		100,000 6.80 US$680,000
2023-05-10 2023-05-09
PlS Planned sale
42,900 -16.9%
5.31
US$227,799 		42,900 -16.9% 5.31 US$227,799
2023-05-10 2023-05-08
PlS Planned sale
57,100 -21.4%
6.16
US$351,736 		57,100 -21.4% 6.16 US$351,736
2023-05-08 2023-05-08
PrS Proposed sale
100,000
6.20
US$620,000 		100,000 6.20 US$620,000
2023-05-10 2022-11-09
S Sale
43,896 -17.3%
4.58
US$201,044 		43,896 -17.3% 4.58 US$201,044